Company profile

Ticker
PLXP
Exchange
CEO
Natasha Giordano
Employees
Incorporated in
Location
Fiscal year end
Former names
Dipexium Pharmaceuticals, Inc., Dipexium Pharmaceuticals, LLC
SEC CIK

PLXP stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

8 Nov 19
13 Nov 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 41.11K 182.91K 317.56K 287.66K
Net income 1.7M -9.35M -10.86M 2.95M
Diluted EPS 0.09 -1.1 -2.71 0.33
Net profit margin 4145% -5110% -3419% 1024%
Operating income -3.68M -3.85M -2.92M -2.52M
Net change in cash -2.75M -3.06M 10.07M -2.29M
Cash on hand 18.51M 21.26M 24.32M 14.25M
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 753.11K 778.66K 20K 0
Net income 896.48K -15.35M -4.91M -18.74M
Diluted EPS 0.1 -2.19 -1.12 -1.99
Net profit margin 119% -1971% -24526%
Operating income -10.96M -15.85M -4.81M -18.76M
Net change in cash -10.15M 7.73M 11.44M -21.81M
Cash on hand 14.25M 24.4M 16.68M 5.23M

Financial data from PLx Pharma earnings reports

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: analytical, denominator, numerator, packaging
Removed: bankruptcy